Immuno Oncology Talks
Adoptive therapy with engineered T cell receptors
januar 25, 2023
00:29:32
Speaker(s)
Reno Debets
In the current, and fifth episode of the “Immuno Oncology Talks”, we discuss adoptive therapy with engineered T cell receptors, with Professor Reno Debets from the Erasmus MC Cancer Institute in the Netherlands. Professor Debets research aims to explore therapeutic strategies by developing and testing adoptive T cell therapy and understand and intervene with the cross-talk between tumor cells and T cells.
For more information please visit:
Sanofi Immuno Oncology Talks website
MAT-BE-2300064 (Ver 1.0) Jan 2023
Also interesting...
![](https://www.myelomaplatform.eu/wp-content/uploads/2023/01/article-tumbnail3-1024x1024.webp)
MGUS, Science
Risk stratification in patients with monoclonal Gammopathies
![](https://www.myelomaplatform.eu/wp-content/uploads/2022/12/immuno_oncology_podcast_img-1.jpeg)
Hematology
Cancer cell and gene therapies and the challenges to access the market
![](https://www.myelomaplatform.eu/wp-content/uploads/2023/02/thumbnail-hematology-podcast.jpeg)
Hematology, Hematology
Hemoglobinopathies
![](https://www.myelomaplatform.eu/wp-content/uploads/2023/02/thumbnail-hematology-podcast.jpeg)
Hematology, Hematology, MRD, Multiple Myeloma
Minimal Residual Disease (MRD) – Cost vs Benefit
![](https://www.myelomaplatform.eu/wp-content/uploads/2023/02/thumbnail-hematology-podcast.jpeg)
Hematology